Navigation Links
People with heart disease still have trouble controlling blood lipid levels
Date:8/7/2008

Irvine, Calif., Aug. 7, 2008 Despite some improvements to lower "bad" cholesterol levels, people with cardiovascular diseases still need to do a better job controlling overall blood lipid levels, according to a UC Irvine Heart Disease Prevention Program study.

Researchers found that 37 percent of Americans with diseases that affect the heart and vascular system had reached recommended levels of LDL-C (bad cholesterol), but only 17 percent were at recommended levels for all lipids LDL-C, HDL-C ("good" cholesterol) and triglycerides. In contrast, 85 percent of those without cardiovascular diseases were at recommended LDL-C levels, while 67 percent were at recommended levels for all lipids.

The study reveals that many adults, particularly those with known cardiovascular diseases, inadequately control these key lipids. Proper diet, exercise, and more appropriate use of therapies to target all lipids are needed, especially for those most at risk, said Nathan D. Wong, study leader and Heart Disease Prevention Program director.

The researchers analyzed data from the nearly 3,000 adults older than 20 who participated in the National Health and Nutrition Examination Survey in 2003-04 and published their findings in the American Heart Journal.

"While national treatment recommendations have focused on aggressive management of LDL-C levels, mainly through statin therapy, we have found little change in HDL-C levels and an actual increase in triglyceride levels," Wong said. "This is not good news, as these factors are important components of cardiovascular risk."

Persons with known cardiovascular diseases should have LDL-C levels below 100 mg (or below 130 mg for most other adults). For all adults, HDL-C levels should be 40 mg or higher for men and 50 mg or higher for women. Triglyceride levels should be below 150 mg.

Obesity and an increasingly sedentary lifestyle are controllable factors that can lead to low HDL-C and elevated LDL-C and triglycerides. High blood pressure, smoking and diabetes can further compound risks associated with high lipid levels.

Wong recommends that all adults have a lipid profile done and speak to their healthcare provider about lifestyle measures and appropriate medications to improve their levels.

Cardiovascular disease is the leading killer of Americans, taking nearly 500,000 lives each year. To decrease risk, doctors recommend that people control their weight, blood pressure and blood lipid levels through good lifestyle habits and minimal stress.


'/>"/>

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine
Source:Eurekalert

Related biology news :

1. Plants can be used to study how and why people respond differently to drugs
2. Fungus genome yielding answers to protect grains, people and animals
3. People who skip meals: are they better off?
4. Energy drinks may pose risks for people with high blood pressure, heart disease
5. Ozone can affect heavier people more
6. Rising food prices threaten worlds poor people
7. New study finds biodiversity conservation secures ecosystem services for people
8. 100 percent of people carry at least 1 type of pesticide
9. Half of the people suffering from head injuries fake to receive financial help
10. People not always needed to alleviate loneliness
11. Gene guards grain-producing grasses so people and animals can eat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
(Date:1/31/2017)...  Spero Therapeutics, LLC, a biopharmaceutical company founded ... bacterial infections, today announced it has acquired a ... Bono Bio Ltd (PBB) to bolster its pipeline ... of Gram-negative bacteria.   The assets acquired have been ... group company. "The acquisition of these ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... Fla. , Feb. 16, 2017  MDNA ... revolutionizing the development of liquid biopsy tests based ... entered into an exclusive license agreement with its ... MDNA,s proprietary liquid biopsy test for prostate cancer, ... South Korea . This is the first ...
(Date:2/16/2017)... Mass. , Feb. 16, 2017   Biostage, ... the "Company"), a biotechnology company developing bioengineered organ implants ... esophagus, bronchus and trachea, announced today the closing on ... of 20,000,000 shares of common stock and warrants to ... proceeds of $8.0 million. The offering was priced at ...
(Date:2/16/2017)... Feb. 16, 2017  Champions Oncology, Inc. (NASDAQ: ... and sale of advanced technology solutions and products to ... announced the addition of new cohorts of PDX models ... models will expand Champions, product line in hepatocellular cancer, ... cancer, AML, and non-small cell lung cancer (including EGFR ...
(Date:2/16/2017)... and NEW YORK , Feb. ... near completion of their $7M Series B financing, adding ... of the $3.5M led by Mesa Verde Venture Partners ... These resources will be directed towards further accelerating commercial ... a comprehensive genomic profiling test and expanding the Paradigm ...
Breaking Biology Technology: